Opyl Ltd (OPL) - Total Liabilities
Based on the latest financial reports, Opyl Ltd (OPL) has total liabilities worth AU$695.82K AUD (≈ $492.33K USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Opyl Ltd - Total Liabilities Trend (1996–2024)
This chart illustrates how Opyl Ltd's total liabilities have evolved over time, based on quarterly financial data. See OPL working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Opyl Ltd Competitors by Total Liabilities
The table below lists competitors of Opyl Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
METALQUEST MINING INC.
F:E7Q
|
Germany | €358.31K |
|
Whitebark Energy Ltd
AU:WBE
|
Australia | AU$5.06 Million |
|
Huachen AI Parking Management Technology Holding Co Ltd
NASDAQ:HCAI
|
USA | $21.65 Million |
|
Kia Lim Bhd
KLSE:6211
|
Malaysia | RM24.19 Million |
|
Comperia.pl S.A.
WAR:CPL
|
Poland | zł12.86 Million |
|
ACG Acquisition Co. Ltd.
LSE:ACG
|
UK | GBX305.14 Million |
|
Proactis SA
PA:PROAC
|
France | €9.67 Million |
|
Salarius Pharmaceuticals Inc
NASDAQ:SLRX
|
USA | $1.85 Million |
Liability Composition Analysis (1996–2024)
This chart breaks down Opyl Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see OPL company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.53 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.47 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.81 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Opyl Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Opyl Ltd (1996–2024)
The table below shows the annual total liabilities of Opyl Ltd from 1996 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | AU$501.76K ≈ $355.03K |
-54.93% |
| 2023-06-30 | AU$1.11 Million ≈ $787.64K |
+56.30% |
| 2022-06-30 | AU$712.21K ≈ $503.93K |
+126.28% |
| 2021-06-30 | AU$314.75K ≈ $222.71K |
+45.32% |
| 2020-06-30 | AU$216.59K ≈ $153.25K |
-70.45% |
| 2019-06-30 | AU$732.96K ≈ $518.62K |
+14.60% |
| 2018-06-30 | AU$639.61K ≈ $452.56K |
+60.72% |
| 2017-06-30 | AU$397.95K ≈ $281.58K |
+79.49% |
| 2016-06-30 | AU$221.72K ≈ $156.88K |
+804.34% |
| 2015-06-30 | AU$24.52K ≈ $17.35K |
-85.28% |
| 2014-06-30 | AU$166.55K ≈ $117.84K |
-44.00% |
| 2013-06-30 | AU$297.38K ≈ $210.42K |
+95.42% |
| 2012-06-30 | AU$152.18K ≈ $107.68K |
-90.00% |
| 2011-06-30 | AU$1.52 Million ≈ $1.08 Million |
+7199.87% |
| 2010-06-30 | AU$20.85K ≈ $14.75K |
-99.53% |
| 2009-06-30 | AU$4.45 Million ≈ $3.15 Million |
-81.74% |
| 2008-06-30 | AU$24.38 Million ≈ $17.25 Million |
+18.47% |
| 2007-06-30 | AU$20.58 Million ≈ $14.56 Million |
+1108.46% |
| 2006-06-30 | AU$1.70 Million ≈ $1.20 Million |
+24.90% |
| 2005-06-30 | AU$1.36 Million ≈ $964.78K |
-46.57% |
| 2004-06-30 | AU$2.55 Million ≈ $1.81 Million |
+621.04% |
| 2003-06-30 | AU$353.95K ≈ $250.44K |
-29.06% |
| 2002-06-30 | AU$498.97K ≈ $353.05K |
-29.94% |
| 2001-06-30 | AU$712.21K ≈ $503.93K |
+178.86% |
| 2000-06-30 | AU$255.40K ≈ $180.71K |
-63.51% |
| 1999-06-30 | AU$700.01K ≈ $495.30K |
+745.31% |
| 1998-06-30 | AU$82.81K ≈ $58.59K |
-48.73% |
| 1997-06-30 | AU$161.53K ≈ $114.29K |
-74.01% |
| 1996-06-30 | AU$621.55K ≈ $439.79K |
-- |
About Opyl Ltd
Pathkey.AI Ltd engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool strea… Read more